[Prevalence of hepatitis B and C virus markers in patients with hepatocellular carcinoma and outpatients with liver dysfunction in Mongolia].
Shizuma
Toru
T
Department of Physiology, School of Medicine, Tokai University.
D015415:Biomarkers / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000821:virology*; D016174:Hepacivirus / Q000302:isolation & purification; D006509:Hepatitis B / Q000453:epidemiology*; D006510:Hepatitis B Antibodies / Q000097:blood; D006515:Hepatitis B virus / Q000302:isolation & purification; D006526:Hepatitis C / Q000453:epidemiology*; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D008107:Liver Diseases / Q000821:virology*; D008113:Liver Neoplasms / Q000821:virology*; D008986:Mongolia / Q000453:epidemiology; D015995:Prevalence
D015415:Biomarkers; D006510:Hepatitis B Antibodies; D018937:Hepatitis C Antibodies